Gene · 406892
Papers3,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role and potential mechanisms of miR‑100 in different diseases (Review). | Oncol Rep | 2025 | 40476555 | PubTator, text mining | PubMed |
| MiR-99 Family of Exosomes Targets Myotubularin-related Protein 3 to Regulate Autophagy in Trophoblast Cells and Influence Insulin Resistance. | J Physiol Investig | 2025 | 40358580 | PubTator, text mining | PubMed |
| Decoding microRNA arm switching: a key to evolutionary innovation and gene regulation. | Cell Mol Life Sci | 2025 | 40347284 | PubTator, text mining | PubMed |
| Key Amniotic Fluid miRNAs as Promising Target Molecules for the Antenatal Prevention of Pulmonary Hypoplasia Associated with Congenital Diaphragmatic Hernia. | Int J Mol Sci | 2025 | 40332537 | PubTator, text mining | PubMed |
| A review shows that ATG10 has been identified as a potential prognostic marker and therapeutic target for cancer patients based on real-world studies. | Front Oncol | 2025 | 40313244 | PubTator, text mining | PubMed |
| Unravelling the role of extracellular vesicles in cervical cancer: Mechanisms of progression, resistance, and emerging therapeutic strategies. | Gene | 2025 | 40204037 | PubTator, text mining | PubMed |
| MicroRNA-99 family in cancer: molecular mechanisms for clinical applications. | PeerJ | 2025 | 40161350 | PubTator, text mining | PubMed |
Charge-reversed small extracellular vesicles from human adipose-derived mesenchymal stromal cells attenuate renal fibrosis postacute kidney injury by inhibiting epithelial-mesenchymal transition progression in SD rat model. | Cytotherapy | 2025 | 40047734 | PubTator, text mining | PubMed |
| miR‑100: A key tumor suppressor regulatory factor in human malignant tumors (Review). | Int J Mol Med | 2025 | 40017111 | PubTator, text mining | PubMed |
| Differential Pattern of Circulating MicroRNA Expression in Patients with Intracranial Atherosclerosis. | Biomedicines | 2025 | 40002927 | PubTator, text mining | PubMed |
| Exosomes in Skin Flap Survival: Unlocking Their Role in Angiogenesis and Tissue Regeneration. | Biomedicines | 2025 | 40002766 | PubTator, text mining | PubMed |
| Extracellular vesicle therapeutics for cardiac repair. | J Mol Cell Cardiol | 2025 | 39603560 | PubTator, text mining | PubMed |
| Small RNA sequencing highlights a potential regulatory network mediated by Gecko miRNA affecting the prognosis of hepatocellular carcinoma. | Adv Clin Exp Med | 2025 | 38683045 | PubTator, text mining | PubMed |
| Transfer of miR-100 and miR-125b increases 3D growth and invasiveness in recipient cancer cells. | Extracell Vesicles Circ Nucl Acids | 2024 | 39697634 | PubTator, text mining | PubMed |
| Prognostic Value of miR-10a-3p in Non-Small Cell Lung Cancer Patients. | Onco Targets Ther | 2024 | 39559728 | PubTator, text mining | PubMed |
| Identification and Experimental Validation of Prognostic miRNA Signature and Ferroptosis-Related Key Genes in Cervical Squamous Cell Carcinoma. | Cancer Med | 2024 | 39526479 | PubTator, text mining | PubMed |
| Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles: A focus on inflammatory bowel disease. | Clin Transl Med | 2024 | 39488745 | PubTator, text mining | PubMed |
| Association of elevated exosomal miR-21 levels with nonunion in clavicular fractures post-ORIF: A prospective analysis. | Injury | 2024 | 39476712 | PubTator, text mining | PubMed |
| Lymph node metastasis determined miRNAs in esophageal squamous cell carcinoma. | Aging (Albany NY) | 2024 | 39401765 | PubTator, text mining | PubMed |
| Autophagy-associated biomarkers ULK2, UVRAG, and miRNAs miR-21, miR-126, and miR-374: Prognostic significance in glioma patients. | PLoS One | 2024 | 39348350 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406892/papers?page=3